Context Therapeutics
CNTX

Context Therapeutics (CNTX) analyst forecast and price target

Analyst forecast

Buy

Consensus of 11 analyst ratings

Buy
10
Hold
1
Sell
0

Recent analyst ratings

FirmActionRatingPrice targetDate
Maxim GroupMaintainedBuy$4.00 from $8.00Jun 16, 2026
Piper SandlerMaintainedOverweight$7.00 from $4.00Mar 24, 2026
GuggenheimMaintainedBuy$5.00Mar 24, 2026
D. Boral CapitalMaintainedBuy$9.00Mar 24, 2026
Jones TradingInitiated CoverageBuy$7.00Dec 22, 2025
HC Wainwright & Co.MaintainedBuy$5.00 from $4.00Nov 6, 2025
D. Boral CapitalMaintainedBuy$9.00Nov 6, 2025
D. Boral CapitalMaintainedBuy$9.00Oct 16, 2025
Cantor FitzgeraldInitiated CoverageOverweightOct 2, 2025
GuggenheimInitiated CoverageBuy$5.00Sep 18, 2025
HC Wainwright & Co.MaintainedBuy$4.00 from $5.00Aug 7, 2025
D. Boral CapitalMaintainedBuy$9.00Aug 7, 2025
Piper SandlerMaintainedOverweight$4.00 from $4.50Jun 26, 2025
D. Boral CapitalMaintainedBuy$9.00May 8, 2025
D. Boral CapitalMaintainedBuy$9.00Apr 29, 2025
William BlairInitiated CoverageOutperformApr 21, 2025
D. Boral CapitalMaintainedBuy$9.00Apr 9, 2025
D. Boral CapitalMaintainedBuy$9.00Mar 21, 2025
HC Wainwright & Co.MaintainedBuy$5.00Mar 21, 2025
D. Boral CapitalMaintainedBuy$9.00Jan 15, 2025

Frequently asked questions

  • Is CNTX a buy, sell, or hold?

    Analysts covering Context Therapeutics currently average a Buy rating: 10 buy, 1 hold and 0 sell, from 11 analysts. Ratings reflect analyst opinion, not investment advice.

  • What is the latest analyst rating on CNTX?

    On Jun 16, 2026, Maxim Group maintained Context Therapeutics at Buy with a price target of $4.00.

Analyst ratings and price targets are the opinions of third-party research firms, not of Light Horse Securities. They are estimates about an uncertain future, are frequently wrong, and are neither a recommendation nor a prediction of actual results.

This page is for informational purposes only. Nothing on it is a recommendation, solicitation or offer to buy or sell any security, nor investment, legal or tax advice. Light Horse Securities Inc does not verify third-party data and is not responsible for its accuracy, completeness or timeliness.